Role of Terminal Warm Blood Cardioplegia as Myocardial Protection in the Use of Histidine-Tryptophan-Ketoglutarate Cardioplegia in Complex Congenital Heart Surgery

NCT02618824 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Congenital Heart Disease

Interventions

DRUG: Histidine Tryptophan Ketoglutarate Solution
OTHER: Terminal Warm Blood Cardioplegia

Sponsor

National Cardiovascular Center Harapan Kita Hospital Indonesia